Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesThe new rosiglitazone story: Its place today in Type 2 diabetes management
Primary Care Diabetes, 07/13/09
Ambery P et al. - Rosiglitazone remains the only oral blood glucose lowering agent to have demonstrated nearly 5 years of blood glucose control. Patients earlier in their disease, free of known cardiovascular disease, are just the patients to benefit most from long term glucose target achievement.
Related Articles
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial)
Diabetes Care, 10/14/09
Relevance Score: 88%
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
Hepatology, 11/02/09
Relevance Score: 87%
Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09
Relevance Score: 87%
Effects of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone
Cardiovascular Drug Reviews, 11/17/09
Relevance Score: 85%
Stretch Reduces Nephrin Expression via an Angiotensin II-AT1-dependent Mechanism in Human Podocytes: Effect of Rosiglitazone
American Journal of Physiology: Renal Physiology, 11/17/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Evidence-Based Medicine, 12/08/09
New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid
Journal of Allergy and Clinical Immunology, 12/08/09
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence of Wet-to-Dry Dressings in Wound Care
Advances in Skin & Wound Care: The Journal for Prevention and Healing, 12/07/09
Acute pancreatitis: Problems in adherence to guidelines
Cleveland Clinic Journal of Medicine, 12/02/09
Marfan syndrome
Journal of the American Academy of Nurse Practitioners, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor